IXHL MEXC RealStocks
Own real IXHL shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-19 05:51:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Incannex Healthcare Limited (IXHL) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $1.79, with a market capitalization of $24.21M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.62 to $14.91. This page covers its latest market performance, valuation, price trends and company information.
$24.21M | |
$1.71 | |
$1.97 | |
$1.62 | |
$1.74 | |
229.63K | |
85.91K | |
-- | |
$14.91 | |
$1.62 | |
-- | |
2026-06-30 |
Incannex Healthcare Limited (IXHL) last closed at $1.79 as of 2026-11-19 00:43:00, up 2.87% ($0.05) from the previous close of $1.74.
During the latest regular trading session, IXHL traded between $1.62 and $1.97, with a volume of 229.63K shares. The closing price was near the middle and near the lower end of its 52-week range.
Over the past seven days, Incannex Healthcare Limited (IXHL) moved from $2.19 to $1.79, representing a decline of 18.36% ($0.40).
The stock traded between $1.62 and $2.28 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 118.46 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 1.3%
IXHL is currently trading at $1.79, placing it 1.3% of the way from its 52-week low of $1.62 to its 52-week high of $14.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Incannex Healthcare Inc is a clinical-stage biopharmaceutical development company dedicated to developing inventive medicines for patients living with serious chronic diseases and unmet needs. The Company's drug candidates include IHL-42X for the treatment of obstructive sleep apnea (OSA) and PSX-001, the Company's psilocybin treatment in combination with psychological therapy in development to treat patients with generalized anxiety disorder (GAD). The Company also has a drug candidate, IHL-675A, for the treatment of rheumatoid arthritis. Each of these programs target conditions that currently have limited, inadequate, or no approved pharmaceutical treatment options. The Company continues to evaluate strategies for IHL-675A when and as resources permit.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 12 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Incannex Healthcare Limited (IXHL) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to IXHL, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between IXHL shares and USD.
IXHL Shares to USD
1.00 IXHL shares = 1.788 USD
Calculations are estimates based on the latest available price and are for reference only.